Tricida, Inc. TCDA today announced that it will report its second quarter 2018 financial results after the close of market on Wednesday, August 8, 2018. Tricida will host a conference call and webcast at 5:00 pm Eastern Time to discuss its financial results and business progress. The call or webcast may be accessed as follows:
Tricida Second Quarter 2018 Conference Call |
|||
August 8, 2018 |
|||
5:00 pm Eastern Time |
|||
Website: |
|||
Dial-in: |
(877) 377-5478 |
||
International: | (629) 228-0740 | ||
Conference ID: |
3097326 |
||
A replay of the webcast will be available on Tricida's website approximately two hours following the completion of the call and will be available for up to 90 days following the presentation.
About Tricida
Tricida, Inc. is a pharmaceutical company focused on the development and commercialization of its product candidate, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease (CKD).
For more information, visit www.tricida.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180731005993/en/
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.